IL160603A0 - C2-disubstituted indan-1-ol systems and their derivatives, processes for their preparation and their use as pharmaceuticals - Google Patents
C2-disubstituted indan-1-ol systems and their derivatives, processes for their preparation and their use as pharmaceuticalsInfo
- Publication number
- IL160603A0 IL160603A0 IL16060302A IL16060302A IL160603A0 IL 160603 A0 IL160603 A0 IL 160603A0 IL 16060302 A IL16060302 A IL 16060302A IL 16060302 A IL16060302 A IL 16060302A IL 160603 A0 IL160603 A0 IL 160603A0
- Authority
- IL
- Israel
- Prior art keywords
- derivatives
- processes
- preparation
- systems
- pharmaceuticals
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical class C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/17—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10142663A DE10142663B4 (de) | 2001-08-31 | 2001-08-31 | C2-Disubstituierte Indan-1-ol-Systeme |
| PCT/EP2002/009203 WO2003020695A1 (de) | 2001-08-31 | 2002-08-17 | C2-disubstituierte indan-1-ol-systeme, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160603A0 true IL160603A0 (en) | 2004-07-25 |
Family
ID=7697234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16060302A IL160603A0 (en) | 2001-08-31 | 2002-08-17 | C2-disubstituted indan-1-ol systems and their derivatives, processes for their preparation and their use as pharmaceuticals |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6982353B2 (es) |
| EP (1) | EP1425264B1 (es) |
| JP (1) | JP4250078B2 (es) |
| AT (1) | ATE412630T1 (es) |
| AU (1) | AU2002336982B2 (es) |
| CA (1) | CA2458523A1 (es) |
| DE (2) | DE10142663B4 (es) |
| IL (1) | IL160603A0 (es) |
| MX (1) | MXPA04001849A (es) |
| PE (1) | PE20030362A1 (es) |
| WO (1) | WO2003020695A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| EP1849465A4 (en) * | 2005-02-18 | 2008-12-24 | Takeda Pharmaceutical | AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050564A (en) | 1958-12-02 | 1962-08-21 | Exxon Research Engineering Co | Preparation of new hydroperoxides by the cooxidation of olefinic compounds and mercaptans |
| US3016349A (en) | 1959-08-10 | 1962-01-09 | Exxon Research Engineering Co | Denitrogenation of petroleum |
| US3043824A (en) | 1959-09-28 | 1962-07-10 | Exxon Research Engineering Co | Hydroperoxide and sulfoxide compounds |
| US3016348A (en) | 1959-11-02 | 1962-01-09 | Universal Oil Prod Co | Manufacture and use of sulfided hydrocarbon purification catalyst |
| YU33726B (en) | 1969-07-04 | 1978-02-28 | Montedison Spa | Process for cross-linking of plastomers |
| US5808062A (en) | 1993-11-19 | 1998-09-15 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
| PT729465E (pt) | 1993-11-19 | 2003-06-30 | Parke Davis & Co | Derivados de pirona como inibidores de protease e agentes antivirais |
| US5622514A (en) | 1995-06-30 | 1997-04-22 | The Whitaker Corporation | Coverless pin grid array socket |
| DE69629387T2 (de) * | 1995-12-06 | 2004-06-24 | Venantius Ltd. | Dimere indan verbindungen und ihre pharmazeutische verwendung |
| EP1826216A1 (en) | 1996-08-30 | 2007-08-29 | Novo Nordisk A/S | Glp-1 derivatives |
| US5985913A (en) | 1996-11-29 | 1999-11-16 | Osi Pharmaceuticals, Inc. | Tetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereof |
| ATE246190T1 (de) | 1996-12-31 | 2003-08-15 | Reddys Lab Ltd Dr | Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten |
| EP0986530A1 (en) | 1997-06-05 | 2000-03-22 | Venantius Limited | Indane compounds and their pharmaceutical use |
| BR9810592A (pt) | 1997-07-16 | 2000-09-12 | Novo Nordisk As | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto |
| DE19844547C2 (de) * | 1998-09-29 | 2002-11-07 | Aventis Pharma Gmbh | Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19908533A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
| EP1078632A1 (en) | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| DE10142660A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142662B4 (de) | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
| DE10142667B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| DE10142666A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142661B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
| DE10142659A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
-
2001
- 2001-08-31 DE DE10142663A patent/DE10142663B4/de not_active Expired - Fee Related
-
2002
- 2002-08-17 IL IL16060302A patent/IL160603A0/xx unknown
- 2002-08-17 AT AT02772163T patent/ATE412630T1/de not_active IP Right Cessation
- 2002-08-17 AU AU2002336982A patent/AU2002336982B2/en not_active Ceased
- 2002-08-17 EP EP02772163A patent/EP1425264B1/de not_active Expired - Lifetime
- 2002-08-17 MX MXPA04001849A patent/MXPA04001849A/es active IP Right Grant
- 2002-08-17 CA CA002458523A patent/CA2458523A1/en not_active Abandoned
- 2002-08-17 WO PCT/EP2002/009203 patent/WO2003020695A1/de not_active Ceased
- 2002-08-17 JP JP2003524966A patent/JP4250078B2/ja not_active Expired - Fee Related
- 2002-08-17 DE DE50212971T patent/DE50212971D1/de not_active Expired - Lifetime
- 2002-08-23 PE PE2002000810A patent/PE20030362A1/es not_active Application Discontinuation
- 2002-08-29 US US10/231,418 patent/US6982353B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20030181491A1 (en) | 2003-09-25 |
| ATE412630T1 (de) | 2008-11-15 |
| PE20030362A1 (es) | 2003-06-02 |
| EP1425264A1 (de) | 2004-06-09 |
| DE50212971D1 (de) | 2008-12-11 |
| US6982353B2 (en) | 2006-01-03 |
| MXPA04001849A (es) | 2004-06-15 |
| DE10142663B4 (de) | 2004-08-19 |
| JP4250078B2 (ja) | 2009-04-08 |
| EP1425264B1 (de) | 2008-10-29 |
| DE10142663A1 (de) | 2003-03-27 |
| CA2458523A1 (en) | 2003-03-13 |
| AU2002336982B2 (en) | 2008-01-31 |
| WO2003020695A1 (de) | 2003-03-13 |
| JP2005501902A (ja) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY132789A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
| MXPA04012965A (es) | Inhibidores virales. | |
| NO20052739L (no) | CCR5-antagonister som medikamenter | |
| NO20055649L (no) | Substituert dihydrokinazolin med antiviale egenskaper | |
| AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| WO1998056761A3 (en) | Benzimidazole derivatives | |
| NO20060415L (no) | Piperidyl-Kinazolinderivater som Tyrosin-Kinase-Inhibitorer | |
| BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
| MX2009004745A (es) | Derivados de 1,2,3-triazol como inhibidores del receptor sigma. | |
| AU2003297048A8 (en) | Cyclohexyl compounds as ccr5 antagonists | |
| NO20082496L (no) | Pyrazinderivater | |
| GB0112348D0 (en) | Compounds | |
| DE60205455T2 (de) | Naphthyridinderivate | |
| WO2002079169A8 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| DK1124841T3 (da) | Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| MXPA04001847A (es) | Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad. | |
| IL161116A0 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
| WO2004037166A3 (en) | Therapeutic guanidines | |
| IL160603A0 (en) | C2-disubstituted indan-1-ol systems and their derivatives, processes for their preparation and their use as pharmaceuticals | |
| IL160604A0 (en) | C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals | |
| IL160601A0 (en) | Use of derivatives of c2-substituted indan-1-ol systems for the preparation of medicaments for the prophylaxis or treatment of obesity | |
| IL160605A (en) | Use of c2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity | |
| SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| MXPA04001853A (es) | Uso de sistemas de indan-1-ona c2-substituida para producir medicamentos para la profilaxis o tratamiento de obesidad. |